AMERIPRISE FINANCIAL INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,247,780
-12.7%
635,778
+58.5%
0.01%0.0%
Q2 2023$16,316,234
+315.6%
401,186
+395.0%
0.01%
+400.0%
Q1 2023$3,926,304
+98.0%
81,055
+56.0%
0.00%0.0%
Q4 2022$1,983,000
+126.4%
51,944
+197.4%
0.00%
Q3 2022$876,000
+22.9%
17,468
-1.8%
0.00%
Q2 2022$713,000
+6.1%
17,789
-1.3%
0.00%
Q1 2022$672,000
+20.2%
18,018
+52.6%
0.00%
Q1 2021$559,000
-66.8%
11,807
-57.2%
0.00%
-100.0%
Q4 2020$1,685,000
-13.0%
27,612
-33.4%
0.00%0.0%
Q3 2020$1,937,000
-34.2%
41,440
-28.5%
0.00%0.0%
Q2 2020$2,942,000
+27.2%
57,990
+11.9%
0.00%0.0%
Q1 2020$2,313,000
+18.7%
51,845
+27.8%
0.00%0.0%
Q4 2019$1,949,000
+43.9%
40,575
+1.4%
0.00%0.0%
Q3 2019$1,354,000
-38.6%
40,031
-18.3%
0.00%0.0%
Q2 2019$2,205,000
-40.8%
49,011
-50.5%
0.00%
-50.0%
Q1 2019$3,724,000
+8.3%
98,926
-1.3%
0.00%0.0%
Q4 2018$3,440,000
+296.8%
100,259
+289.7%
0.00%
Q2 2018$867,000
+26.0%
25,724
+1.2%
0.00%
Q1 2018$688,000
+58.5%
25,412
-2.2%
0.00%
Q4 2017$434,000
-72.9%
25,996
-67.5%
0.00%
-100.0%
Q3 2017$1,600,000
-80.2%
79,961
-81.9%
0.00%
-75.0%
Q2 2017$8,089,000
+25.7%
441,473
-32.5%
0.00%
+33.3%
Q1 2017$6,434,000
+127.7%
653,901
+152.4%
0.00%
+50.0%
Q4 2016$2,826,000
-56.9%
259,023
-44.6%
0.00%
-50.0%
Q3 2016$6,552,000
+133.7%
467,619
+17.1%
0.00%
+100.0%
Q2 2016$2,803,000
+31.5%
399,168
+20.5%
0.00%
+100.0%
Q1 2016$2,132,000
-2.5%
331,243
+391.2%
0.00%0.0%
Q4 2015$2,186,000
+1.4%
67,432
-16.4%
0.00%0.0%
Q3 2015$2,155,000
-50.5%
80,694
-10.8%
0.00%
-50.0%
Q2 2015$4,354,000
-0.4%
90,484
+26.0%
0.00%
-33.3%
Q1 2015$4,371,000
+51.2%
71,817
+28.7%
0.00%
+50.0%
Q4 2014$2,890,000
+90.6%
55,812
+62.0%
0.00%
+100.0%
Q3 2014$1,516,000
-6.1%
34,442
-44.2%
0.00%0.0%
Q2 2014$1,614,00061,7570.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders